ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Toxicology Letters

• Publication date

  2013-12-16

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.toxlet.2013.03.027PMID 23558296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.

  2013cited by this paper
• Science based guidance for the assessment of endocrine disrupting properties of chemicals.

  2011cited by this paper
• Corrigendum to “Science based guidance for the assessment of endocrine disrupting properties of chemicals” [Regul. Toxicol. Pharmacol. 59 (2011) 37–46]

  2011cited by this paper
• IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans

  2008cited by this paper
• IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans

  2006cited by this paper
• Neoplastic Lesions of Questionable Significance to Humans

  1994cited by this paper
• Ranking possible carcinogenic hazards.

  1987cited by this paper

• A critical review finds styrene lacks direct endocrine disruptor activity

  2015cites this paper
• Endocrine disruption: fact or urban legend?

  2013cites this paper